Merck & Co Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Merck & Co Inc
CIK #0000310158
Sector Form 13F Holdings Value ($M)
Moderna Inc 117.3
Personalis Inc 89.5
Kymera Therapeutics Inc 64.3
Alector Inc 7.6
Sutro Biopharma Inc 6.8
Evaxion Biotech A/S 4.5
Signal Genetics Inc 1.8
Xilio Therapeutics Inc 0.9
Bionomics Limited/Fi 0.0
Berry Only Inc 0.0
Holdings by Sector ($M)
3502802101407002023202420252027
EDGAR Form CIK 2011 - 2026
10-K [0000310158]
10-Q [0000310158]
13F-HR [0000310158]
3 [0000310158]
4 [0000310158]
5 [0000310158]
8-K [0000310158]
SC 13D [0000310158]
SC 13G [0000310158]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Capital Management LLC Merck & Co Inc [2026-04-30]
Merck & Co Inc Personalis Inc [2024-12-23]
Merck & Co Inc Evaxion Biotech A/S [2024-01-23]
Merck & Co Inc 4D Pharma PLC [2022-02-02]
Merck & Co Inc Pandion Therapeutics Inc [2021-03-04]
Merck & Co Inc Yumanity Therapeutics Inc [2021-01-04]
Merck & Co Inc Arqule Inc [2019-12-16]
Merck & Co Inc NGM Biopharmaceuticals Inc [2019-04-09]
Merck & Co Inc Alector Inc [2019-02-14]
Merck & Co Inc Sutro Biopharma Inc [2018-10-04]
Merck & Co Inc Menlo Therapeutics Inc [2018-02-14]
Merck & Co Inc Spero Therapeutics Inc [2017-11-15]
Merck & Co Inc KalVista Pharmaceuticals Inc [2017-10-16]
Capital World Investors Merck & Co Inc [2017-02-13]
Merck & Co Inc BeiGene Ltd [2016-02-12]
Vanguard Group Inc Merck & Co Inc [2015-02-11]
Merck & Co Inc Idenix Pharmaceuticals Inc [2014-06-13]
Wellington Management Co LLP Merck & Co Inc [2014-02-14]
Form 3/4/5 Subject 2011 - 2026
Merck & Co Inc
Coe Mary Ellen
Seidman Christine E
Karsanbhai Surendralal Lanca
Thulin Inge G
Russo Patricia F
Rothman Paul
Mayo Stephen
Lavizzo-Mourey RISA J
Glocer Thomas H
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Merck & Co Inc MRK
Common Stock
2026-02-12 Sell 10,000 $121.46 1,214,600
Merck & Co Inc MRK
Common Stock
2026-02-10 Sell 10,235 $117.52 1,202,817
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
2026-02-09 Option exercise 56,792 $0.00
Merck & Co Inc MRK
Common Stock
2026-02-09 Sell 10,000 $118.41 1,184,100
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
2026-02-09 Option exercise 38,835 $0.00
Merck & Co Inc MRK
Common Stock
2026-02-09 Option exercise 25,946 $119.15 3,091,466
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
2026-02-09 Option exercise 25,946 $0.00
Merck & Co Inc MRK
Common Stock
2026-02-09 Sell 25,946 $119.15 3,091,466
Merck & Co Inc MRK
Common Stock
2026-02-09 Option exercise 38,835 $119.15 4,627,190
Merck & Co Inc MRK
Common Stock
2026-02-09 Option exercise 56,792 $119.15 6,766,767
Merck & Co Inc MRK
Common Stock
2026-02-09 Sell 56,792 $119.15 6,766,767
Merck & Co Inc MRK
Common Stock
2026-02-09 Sell 38,835 $119.15 4,627,190
Merck & Co Inc MRK
Common Stock
2026-02-06 Sell 37,685 $120.92 4,556,870
Merck & Co Inc MRK
Common Stock
2026-02-06 Sell 15,000 $121.87 1,828,050
Merck & Co Inc MRK
Common Stock
2026-02-06 Option exercise 5,000 $77.62 388,100
Merck & Co Inc MRK
Common Stock
2026-02-06 Sell 5,000 $121.91 609,550
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
2026-02-06 Option exercise 5,000 $0.00
Merck & Co Inc MRK
Common Stock
2026-02-05 Sell 20,000 $121.88 2,437,600
Merck & Co Inc MRK
Common Stock
2026-02-04 Sell 41,997 $119.61 5,023,261
Merck & Co Inc MRK
Common Stock
2026-02-04 Option exercise 15,087 $56.04 845,475
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com